Nurix Therapeutics Ratios (2019-2025) | NRIX

Ratios Aug2019 Nov2019 Feb2020 May2020 Aug2020 Nov2020 Feb2021 May2021 Aug2021 Nov2021 Feb2022 May2022 Aug2022 Nov2022 Feb2023 May2023 Aug2023 Nov2023 Feb2024 May2024 Aug2024 Nov2024 Feb2025 May2025 Aug2025 Nov2025
Profitability
EBT Margin -22.84%-714.77%-432.26%-311.02%-453.29%-297.10%-483.02%-370.09%-282.46%-509.17%-442.09%-397.14%-423.58%-688.74%-321.11%-79.14%-200.26%-276.77%-249.79%-367.65%-388.26%-440.69%-305.38%-96.93%-1,094.77%-576.13%
EBIT Margin -24.69%-728.46%-438.30%-316.36%-469.82%-299.12%-489.36%-372.50%-282.84%-513.16%-444.28%-399.89%-432.93%-717.82%-338.60%-87.25%-216.67%-299.06%-272.65%-401.42%-433.83%-486.73%-340.67%-109.68%-1,157.65%-612.03%
EBITDA Margin -24.69%-728.46%-438.30%-316.36%-469.82%-299.12%-489.36%-372.50%-282.84%-513.16%-444.28%-399.89%-432.93%-717.82%-338.60%-87.25%-216.67%-299.06%-272.65%-401.42%-433.83%-486.73%-340.67%-109.68%-1,157.65%-612.03%
Operating Margin -24.69%-728.46%-438.30%-316.36%-469.82%-299.12%-489.36%-372.50%-282.84%-513.16%-444.28%-399.89%-432.93%-717.82%-338.60%-87.25%-216.67%-299.06%-272.65%-401.42%-433.83%-486.73%-340.67%-109.68%-1,157.65%-612.03%
Net Margin -22.94%-726.05%-432.65%181.25%-453.29%-297.44%-484.43%-372.05%-281.26%-509.59%-442.09%-397.14%-423.58%-688.74%-321.11%-79.14%-200.26%-276.77%-250.33%-368.39%-388.91%-440.75%-305.38%-98.66%-1,094.77%-576.13%
FCF Margin -735.82%1,417.88%-383.60%-191.21%-319.75%143.88%-474.21%-310.54%-429.60%-479.18%-312.31%-460.81%-597.38%-399.91%-63.73%-236.05%159.01%-270.33%-344.38%-353.70%-382.84%-349.93%-149.44%-761.29%-537.40%
Efficiency
Assets Average 404.11M396.50M457.32M505.53M484.92M457.25M416.01M426.82M438.05M393.46M360.39M329.41M331.90M334.14M411.85M512.32M591.47M642.19M603.30M557.01M605.30M
Equity Average -51.08M298.94M280.20M334.16M386.70M358.76M324.11M286.33M304.64M323.12M288.87M266.99M246.87M217.16M184.62M269.72M373.77M451.92M503.95M464.26M409.93M455.50M
Invested Capital -44.44M-57.71M307.62M290.27M270.13M398.18M375.22M342.30M305.92M266.74M342.55M303.70M274.05M259.92M233.82M200.49M168.75M370.69M376.86M526.99M480.92M447.60M372.25M538.75M
Asset Utilization Ratio 0.040.050.050.060.060.080.090.090.090.110.170.210.230.240.150.110.090.090.150.150.14
Leverage & Solvency
Equity Ratio -1.310.750.730.680.770.760.720.700.680.750.730.740.740.760.560.540.730.730.790.780.760.710.78
Valuation
Enterprise Value -51.85M-37.72M-354.24M-281.15M-303.07M-386.02M-343.90M-295.72M-261.98M-297.28M-344.48M-309.14M-277.15M-281.18M-258.85M-287.91M-243.99M-443.14M-448.05M-609.58M-549.68M-485.78M-428.83M-592.94M
Return Ratios
Return on Sales -0.23%-7.26%-4.33%1.81%-4.53%-2.97%-4.84%-3.72%-2.81%-5.10%-4.42%-3.97%-4.24%-6.89%-3.21%-0.79%-2.00%-2.77%-2.50%-3.68%-3.89%-4.41%-3.05%-0.99%-10.95%-5.76%
Return on Capital Employed -0.18%-0.22%-0.22%-0.22%-0.28%-0.35%-0.45%-0.48%-0.50%-0.56%-0.57%-0.59%-0.63%-0.64%-0.54%-0.45%-0.43%-0.42%-0.44%-0.56%-0.55%
Return on Invested Capital -0.15%-0.20%-0.27%-0.26%-0.33%-0.42%-0.54%-0.57%-0.85%-0.66%-0.52%-0.47%-0.46%-0.50%-0.65%-0.63%
Return on Assets -0.11%-0.14%-0.19%-0.20%-0.24%-0.30%-0.37%-0.40%-0.41%-0.45%-0.44%-0.45%-0.43%-0.43%-0.40%-0.35%-0.33%-0.32%-0.34%-0.44%-0.44%
Return on Equity -0.14%-0.20%-0.27%-0.26%-0.33%-0.42%-0.54%-0.56%-0.56%-0.62%-0.59%-0.60%-0.66%-0.78%-0.61%-0.47%-0.43%-0.41%-0.45%-0.60%-0.58%